The prognosis of KIT, KDR, CHIC2, EXOC1, IGFBP7, RASL11B or USP46 was further tested in CGGA, GSE13041 and GSE83300 three independent GBM cohorts. This evidence concerns the gene CHIC2 and glioblastoma.